SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001013594-14-000424
Filing Date
2014-05-19
Accepted
2014-05-19 16:17:27
Documents
2
Effectiveness Date
2014-05-19

Document Format Files

Seq Description Document Type Size
1 MAY 19, 2014 echodfan14a-051914.htm DFAN14A 67789
2 THREE YEAR PRICE PERFORMANCE echodfan14a-0519140.jpg GRAPHIC 48963
  Complete submission text file 0001013594-14-000424.txt   137344
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Subject) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-35218 | Film No.: 14854820
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 212-581-0500
Platinum Partners Value Arbitrage Fund, LP (Filed by) CIK: 0001299265 (see all company filings)

IRS No.: 141861954 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DFAN14A